| Tumor microenvironment complexity and therapeutic implications at a glance R Baghban, L Roshangar, R Jahanban-Esfahlan, K Seidi, ... Cell Communication and Signaling 18, 1-19, 2020 | 1289 | 2020 |
| Yeast expression systems: overview and recent advances R Baghban, S Farajnia, M Rajabibazl, Y Ghasemi, AA Mafi, R Hoseinpoor, ... Molecular biotechnology 61, 365-384, 2019 | 214 | 2019 |
| New developments in Pichia pastoris expression system, review and update R Baghban, S Farajnia, Y Ghasemi, M Mortazavi, N Zarghami, N Samadi Current pharmaceutical biotechnology 19 (6), 451-467, 2018 | 50 | 2018 |
| Camelid‐derived heavy‐chain nanobody against Clostridium botulinum neurotoxin E in Pichia pastoris R Baghban, SLM Gargari, M Rajabibazl, S Nazarian, H Bakherad Biotechnology and applied biochemistry 63 (2), 200-205, 2016 | 43 | 2016 |
| Recent achievements in nano-based technologies for ocular disease diagnosis and treatment, review and update M Afarid, S Mahmoodi, R Baghban Journal of Nanobiotechnology 20 (1), 361, 2022 | 32 | 2022 |
| Combination therapy with KRAS siRNA and EGFR inhibitor AZD8931 suppresses lung cancer cell growth in vitro H Zarredar, S Pashapour, K Ansarin, M Khalili, R Baghban, S Farajnia Journal of cellular physiology 234 (2), 1560-1566, 2019 | 29 | 2019 |
| Chitosan-based biomaterials for the treatment of bone disorders M Rahimi, SM Mir, R Baghban, G Charmi, CM Plummer, ... International Journal of Biological Macromolecules 215, 346-367, 2022 | 25 | 2022 |
| Were magnetic materials useful in cancer therapy? R Baghban, M Afarid, J Soleymani, M Rahimi Biomedicine & Pharmacotherapy 144, 112321, 2021 | 24 | 2021 |
| Development and characterization of a novel conductive polyaniline-g-polystyrene/Fe3O4 nanocomposite for the treatment of cancer AA L Ahmadkhani, E Mostafavi, S Ghasemali, R Baghban, H Pazoki-Toroudi, S ... Artificial cells, nanomedicine, and biotechnology 47 (1), 873-881, 2019 | 20 | 2019 |
| Nucleic acid-based vaccine platforms against the coronavirus disease 19 (COVID-19) R Baghban, A Ghasemian, S Mahmoodi Archives of Microbiology 205 (4), 150, 2023 | 15 | 2023 |
| New developments in anti-angiogenic therapy of cancer, review and update S Ghasemali, S Farajnia, A Barzegar, M Rahmati-Yamchi, R Baghban, ... Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2021 | 15 | 2021 |
| Association of rs780094 polymorphism of glucokinase regulatory protein with non-alcoholic fatty liver disease S Mohammadi, S Farajnia, M Shadmand, F Mohseni, R Baghban BMC Research Notes 13, 1-5, 2020 | 15 | 2020 |
| Current trends in targeted therapy for drug-resistant infections L Rahbarnia, S Farajnia, B Naghili, V Ahmadzadeh, K Veisi, R Baghban, ... Applied microbiology and biotechnology 103, 8301-8314, 2019 | 14 | 2019 |
| Design and in silico evaluation of a novel cyclic disulfide-rich anti-VEGF peptide as a potential antiangiogenic drug R Baghban, S Ghasemali, S Farajnia, R Hoseinpoor, S Andarzi, ... International Journal of Peptide Research and Therapeutics 27, 2245-2256, 2021 | 12 | 2021 |
| CRISPR‐Cas system: Toward a more efficient technology for genome editing and beyond V Ahmadzadeh, S Farajnia, R Baghban, L Rahbarnia, H Zarredar Journal of Cellular Biochemistry 120 (10), 16379-16392, 2019 | 11 | 2019 |
| Engineering of ocriplasmin variants by bioinformatics methods for the reduction of proteolytic and autolytic activities R Baghban, S Farajnia, Y Ghasemi, M Mortazavi, S Ghasemali, ... Iranian Journal of Medical Sciences 46 (6), 454, 2021 | 5 | 2021 |
| Mutational Analysis of Ocriplasmin to Reduce Proteolytic and Autolytic Activity in Pichia pastoris R Baghban, S Farajnia, Y Ghasemi, R Hoseinpoor, A Safary, M Mortazavi, ... Biological Procedures Online 22, 1-12, 2020 | 5 | 2020 |
| Recent advancements in nanomaterial-laden contact lenses for diagnosis and treatment of glaucoma, review and update R Baghban, MR Talebnejad, A Meshksar, M Heydari, MR Khalili Journal of Nanobiotechnology 21 (1), 402, 2023 | 3 | 2023 |
| WITHDRAWN: nucleic acid-based vaccines platform against Covid-19 pandemic R Baghban, S Mahmoodi Current molecular medicine, 2022 | 1 | 2022 |
| Assessment of E. coli Expression System for Overexpression of Active Recombinant Ocriplasmin R Baghban, S Farajnia, Y Ghasemi, M Mortazavi, N Samadi, N Zarghami Advanced Pharmaceutical Bulletin 11 (3), 564, 2021 | 1 | 2021 |
Professor S. FarajniaTabriz University of Medical sciences在 tbzmed.ac.ir 的电子邮件经过验证
